Assessing the Frequency of Deferrable Thyroid Nodule Biopsies to De-Escalate Low-Value Care

•We assessed appropriate use of thyroid nodule evaluation at our academic center.•Patients with limited life expectancy underwent 1.5% of thyroid nodule biopsies.•These patients rarely underwent thyroid surgery regardless of biopsy results.•Procedure charges associated with low-value biopsies totaled nearly $285,000.•Multidisciplinary collaboration may help reduce the frequency of low-value biopsies.